About the Webconference
Proton therapy is a controversial topic in health care. As an expensive, disruptive technology, it is in the cross-hairs of public and private payers alike, and caught in the transitory space between the fee-for-service world that helped develop it, and the accountable care environment that is directing its evolution.
This presentation, from the keynote speech delivered by Advisory Board researchers at the National Proton Conference in April 2014, examines trends around this technology and arm strategic planners, decision makers, and clinicians with the latest information on the disruptive potential of proton therapy in their market.
This webconference also examines:
- What’s new and what’s coming in the proton therapy market
- How proton therapy will affect your market
- Strategies and best practices for bringing the technology to your institution
Presenters: David Gaffin & Catherine Castillo